ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors
for Non Small Cell Lung Cancer
46 locations incl. Dothan
Sponsor: OncoC4, Inc.
Sex: All·Age: 18+
Code: NCT05671510·Phase 3·Recruiting·Listed Jan 2023
Clinical research site in Henrico, Virginia
Part of Virginia Cancer Institute
As of July 2026, 1 paid clinical trial is recruiting at Virginia Cancer Institute - 1149 in Henrico, Virginia. Active studies at this site focus on Non Small Cell Lung Cancer alongside other indications. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Paid clinical trials in Henrico, VA · Virginia clinical trials